Logo

    Ep.15 - David Hunt, CEO of The Considered: Breaking the Rules in Pharma Advertising

    enNovember 05, 2021
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    In this podcast interview, R.J. Lewis talks with David Hunt, the CEO of the independent agency, The Considered, about how they are breaking the rules in pharma advertising.

    David discusses and answers questions around:

    • How The Considered is different.
    • What launched the conception of the agency?
    • What rules is The Considered breaking?
    • The new working normal and how The Considered is leveraging it for successful outcomes for their clients and their audiences.

     

    Recent Episodes from The Pharma Marketing Podcast

    Organizational Design: How Can Pharma Keep Optimizing As Everything Business Keeps Changing

    Organizational Design: How Can Pharma Keep Optimizing As Everything Business Keeps Changing

    Pharma companies are highly matrixed organizations, which presents challenges in handoffs, overlaps between roles and functions, access to data and accountability of who owns and acts on this data in a timely manner. Therefore, instigating change at an organizational level is difficult, and takes much longer than anticipated.
    This podcast will share insights and experiences from Ozgun Demir, Head of Digital Marketing at Genentech on:

    • Change management, resource management: how you ready the organization to take in whatever capabilities you're building
    • Data and measurement: ensuring marketers get access to the data in a timely manner
    • Accountability: ensuring overlapping roles act efficiently and expediently both with data and technology
    • Enacting a learning agenda: Genentech's approach to ensuring everyone - at an enterprise level - understands the same language, terminology and definitions
    • In-housing of media vs. moving therapeutic area level of engagement to an enterprise level of engagement

    The Pharma Marketing Podcast
    enSeptember 20, 2023

    Horizon Therapeutics' Experiences with Executing Multiple Highly Innovative Campaigns Simultaneously to Challenge Disease State Misperceptions, Create Urgency and Change Treatment Behaviors

    Horizon Therapeutics' Experiences with Executing Multiple Highly Innovative Campaigns Simultaneously to Challenge Disease State Misperceptions, Create Urgency and Change Treatment Behaviors

    Toxic Portraits:

    Gout is traditionally viewed as a low-priority disease with misperceptions driving the narrative. To change those misperceptions, we must be creative and bring the impact of this condition to the forefront. Toxic Portraits provide an innovative way to look at a disease state often overlooked.  This entirely different approach to creating urgency to treat uncontrolled gout focuses on the toxic source of the disease: uric acid. Horizon's objective: Educate healthcare providers by demonstrating the toxic effects of uric acid to potentially change treatment behavior and show them the disease like never before.
    -
    Augmented Reality / Experiential Booth at the National Kidney Foundation Event:

    Nephrologists treat patients with chronic kidney disease, but a lot of their patients also have gout.  If left untreated, gout threatens many organs and systems, including the heart and the kidney. Horizon needed to stand out among all the exhibitors at the National Kidney Foundation conference to make them take gout seriously, to show doctors the systemic effects of uric acid buildup.  The
    objective: create a booth that would be impossible to ignore, in order to show healthcare providers, the truth—that gout could be almost anywhere.
    _
    View this podcast to understand 'the how' and the pull through, where the success was built on.

    Pharma Marketers Need AI Now: How to deliver a truly personalized, omnichannel experience for your patients, with William Grambley, CEO of Allazo Health

    Pharma Marketers Need AI Now: How to deliver a truly personalized, omnichannel experience for your patients, with William Grambley, CEO of Allazo Health

    Marketing in the era of consumer-driven healthcare requires new tools and techniques. If you want patients to initiate therapy, you need to connect across more channels, more personally, and in the ways consumers prefer to be engaged. Plus, given today’s budget realities, you’re likely being asked to achieve more with less. In this podcast, William Grambley, CEO of AllazoHealth, explains how pharma marketers can reach their omni-channel engagement objectives with artificial intelligence (AI), anticipate patient intent, and drive next-best-action at the individual level. With AI, pharma marketers can finally truly personalize campaigns, increase therapy initiation and medication adherence, and deliver marketing operations efficiency at scale.

    The Pharma Marketing Podcast
    enFebruary 22, 2023

    Cultural Competence for Global Marketing

    Cultural Competence for Global Marketing
    Tune in to this episode of the Pharma marketing Podcast, with our guest Wendy Pease, President of Rapport International and the author of The Language of Global Marketing for a conversation on why pharma should be thinking global from the start, addressing how to keep a consistent brand globally, and the many things that need to be considered when curating your global market.

    Ep. 18: Law Changes and Updates: What Pharma Marketers Need to Know

    Ep. 18: Law Changes and Updates: What Pharma Marketers Need to Know

    Tune in to this episode, Law Changes and Updates: What Pharma Marketers Need to Know, with our friend and Editorial Advisory Board member and returning guest,  Darshan Kulkarni, Attorney of Law at the Kulkarni Law Firm which advises life science companies and their advisors including marketing and PR agencies with compliance issues, promotional review, audits and training. He is also a Pharmacist, Book Author and Professor, and host of the world famous Darshantalks podcast which focuses on emerging life science issues. He is joined by the incomparable Jennifer Ginest, Digital Marketing Manager at the Pharma Marketing Network. Find out what law and regulation changes could impact your brand now and in the future.

    Ep. 17: A Continuation Into the Role of Digital Therapeutics in Healthcare - Jennifer Ginest and Chris Wasden of Happify Health

    Ep. 17: A Continuation Into the Role of Digital Therapeutics in Healthcare - Jennifer Ginest and Chris Wasden of Happify Health

    Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Chris Wasden, Head of Pharma Specialty Solutions & Corporate Strategy at Happify Health and Jennifer Ginest, Digital Marketing Manager of PMN discuss the current role of Digital Therapeutics in Healthcare and were it is headed.

    Ep. 16 How Biotech and Pharma Companies are Using Technology to Improve CX - Jennifer Ginest and Robert Schildt of Biohaven Pharmaceuticals

    Ep. 16 How Biotech and Pharma Companies are Using Technology to Improve CX - Jennifer Ginest and Robert Schildt of Biohaven Pharmaceuticals

    Tune in to this episode of the PMN podcast to hear from our guest, Robert Schildt, Senior Director of Go-To-Market Innovation at Biohaven Pharmaceuticals and Jennifer Ginest, Digital Marketing Manager of PMN discuss how digital is being used to engage and personalize the CX experience in pharma.